Exogenous glucagon-like peptide-1 (GLP-1) attenuates the glycaemic response to small intestinal nutrient in the critically ill.

Phase 2

Completed

• Conditions: Blood Glucose; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12609000093280
• Lead Sponsor: Adam Deane

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-02-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

Inclusion criteria
Critically ill patients who require artificial ventilation
Likely to be ventilated for >48hrs
Suitable to receive enteral nutrition via naso-jejunal feeding tube

Exclusion Criteria

Age <18
Age>85
Pregnancy
Small bowel obstruction
History of diabetes
Previous surgery on the oesophagus, stomoach or duodenum
Any gastrointestinal surgery on this admission

Study & Design

• Study Type: Interventional
• Study Design: Not specified